Author
Zhang Q
- Indexed works
- 13
- Total citations
- 5
- Active years
- 2
Collaborators
Works in the record
Biomedicines 2025
Open access · OA
Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges.
NPJ Regenerative medicine 2026
Open access · OA
Multi-omics profiling reveals systemic rejuvenation of the aged kidney through senolytic therapy.
Cells 2026
Open access · OA
Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications.
Science advances 2026
Open access · OA
Predicting and finding geroprotective compounds through modulating conserved longevity-associated aging modules.
Frontiers in immunology
Open access · OA
The role of the gut–lung axis in persistent inflammation and disease progression in chronic obstructive pulmonary disease: mechanistic evidence and therapeutic implications
2026
Preprint
Cross-Tissue Inflammatory Convergence Supports a Putative Muscle-Brain Axis in Alzheimer's Disease
International journal of molecular sciences 2026
Open access · OA
Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.
2026
Preprint
A mesoporous oxygen-vacancy-rich ZnO nanoplatform as a catalytic therapeutic hub for osteoarthritis therapy by TRIM15-targeted stem cell rejuvenation
International journal of nanomedicine 2026
Open access · OA
Exosome-Based Therapies for Skin Aging: Sources, Mechanisms, and Evidence from Preclinical and Clinical Studies.
Diabetes, metabolic syndrome and obesity : targets and therapy 2026
Open access · OA
Interactive Pathways and Therapeutic Innovations in Elderly Sarcopenia-Diabetes Comorbidity: Breaking the Negative Self-Reinforcing Loop Through Integrated Care.
Research (Washington, D.C.)
Open access · OA
Cell Reprogramming: Therapeutic Advances and Challenges
Research (Washington, D.C.) 2026
Open access · OA
Cell Reprogramming: Therapeutic Advances and Challenges.
Microbiome 2026
Open access · OA